FOXO1 and autism: These findings suggest that higher dose Rg1 may exert stronger neuroprotective effects by enhancing Sirt2 expression and regulating Foxo1 activity, thereby contributing to improved synaptic plasticity and behavioral outcomes in VPA‐induced autism‐like phenotypes.